Trump Win Is False Security For Drug Makers, Allergan CEO Warns
Executive Summary
Industry should act on drug pricing now while there is a post-election reprieve, Allergan CEO Brent Saunders said during the Forbes Healthcare Summit. Trump is a populist who will jump on the next big pricing scandal, he said.
You may also be interested in...
Saunders: Industry Must Act Before We Lose Champions For Innovation In Congress
Allergan CEO Brent Saunders, speaking at the BIO International Convention on June 19, said the biopharma industry needs to improve its image before its defenders in Congress bow to public pressure on drug pricing concerns.
The Bully Pulpit: Trump Versus Drug Prices
Medicare price negotiation is not a new idea – nor is the concept of using the Presidential megaphone to talk down drug prices. Will Trump and Twitter turn it into something bigger?
Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan
Pharmaceutical manufacturers have been waiting for Trump’s ax to fall – and it finally did, on the final full day of the industry’s biggest business meeting of the year.